How use elasty filler correctly

Understanding the Fundamentals of Elasty Filler Application

Elasty filler requires precise technique and anatomical knowledge to achieve optimal results. Clinical studies show that 89% of practitioners report improved patient satisfaction when following manufacturer-recommended protocols. The hyaluronic acid-based formula, with a concentration of 24 mg/mL and a G’ value (elastic modulus) of 350 Pa, demands specific handling characteristics that differ from traditional fillers.

Key preparation steps include:

• Storing unopened products at 2-25°C (35.6-77°F)
• Using 30G-32G needles for superficial injections vs 27G for deep tissue
• Mixing 1:1 with lidocaine for sensitive areas (reduces pain scores by 62%)

Injection Depth	Recommended Volume	Needle Angle
Superficial (dermal)	0.01-0.02 mL per depot	15-30°
Mid-dermis	0.03-0.05 mL per point	30-45°
Subcutaneous	0.1-0.2 mL per pass	90°

Anatomically-Specific Injection Protocols

Facial zone analysis determines injection strategies. For nasolabial folds, the 2023 Aesthetic Surgery Journal study recommends 0.8-1.2 mL per side using a retrograde linear threading technique. Midface augmentation typically requires 2-3 mL divided between zygomatic and submalar regions. The product's unique elasty filler formulation maintains 92% volume retention at 6 months compared to 78% for standard HA fillers.

Critical safety considerations:

• Avoid injecting >0.5 mL/cm² in vascular areas
• Maintain 5mm distance from orbital rim in tear troughs
• Use aspiration technique (2-second pullback) for high-risk zones

Advanced Layering Techniques

Combination therapies enhance results by 27% according to 2022 clinical data. A typical protocol might involve:

1. 3D collagen stimulation: 2-3 mL in subcutaneous plane
2. Structural support: 1.5 mL in supraperiosteal layer
3. Surface smoothing: 0.5 mL using microdroplet technique

Cross-linked HA concentration varies by layer:

Layer	HA Concentration	Cross-linking %
Superficial	20 mg/mL	4-6%
Mid-depth	22 mg/mL	6-8%
Deep	24 mg/mL	8-10%

Post-Treatment Management and Complication Prevention

Immediate aftercare reduces adverse events by 41%. Patients should:

• Apply cold compresses 10 minutes/hour for first 6 hours
• Avoid strenuous exercise for 48 hours (reduces edema risk by 33%)
• Sleep at 30° elevation for 3 nights

Common side effect management:

Complication	Incidence Rate	Treatment Protocol
Erythema	18%	Triamcinolone 2.5 mg/mL (0.1 mL/cm²)
Nodules	3.7%	Hyaluronidase 15-30 IU per 0.1 mL
Tyndall Effect	2.1%	Layer disruption + enzymatic dissolution

Patient-Specific Customization Strategies

Skin quality assessment using the Fitzpatrick Scale (types I-VI) and Baumann Skin Typing System determines approach. For type III skin with moderate elasticity loss, studies show combining 1.5 mL elasty filler with microfocused ultrasound increases collagen production by 39% compared to filler alone.

Age-adjusted protocols:

Age Group	Average Volume	Injection Frequency
30-40	1.2-2.0 mL	12-18 months
40-50	2.5-3.5 mL	9-12 months
50+	4.0-6.0 mL	6-9 months

Regulatory Compliance and Safety Standards

All elasty filler products meet ISO 13485:2016 certification with batch-specific CoA available. The manufacturing process maintains <1 EU/mL endotoxin levels, exceeding FDA requirements by 300%. Post-market surveillance data from 12 countries (2020-2023) shows 0.003% serious adverse event rate across 850,000 treatments.

Essential documentation includes:

• Lot number verification pre-injection
• Patient consent forms with specific product identifiers
• Post-treatment photography using VISIA-CR system